NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Navidea Biopharmaceuticals, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2022.
  • Navidea Biopharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$5.71M, a 134% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.2M, a 29.4% decline from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$11.7M.
  • Navidea Biopharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2016 was -$14.3M, a 48.1% increase from 2015.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$5.71M -$3.27M -134% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q3 2021 -$2.44M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2017 $75.1M -$1.39M -$1.33M -2240% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $76.5M -$5.19M +$1.49M +22.4% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $75M $85.6M +$89.3M Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$14.3M -$3.88M Oct 1, 2016 Dec 31, 2016 8-K 2017-12-15
Q3 2016 -$59.4K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$6.68M +$3.01M +31.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.69M +$3.6M +49.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q2 2015 -$30.7M -$9.69M +$531K +5.2% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-10
Q1 2015 -$31.3M -$7.29M +$4.45M +37.9% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 -$35.7M -$6.87M +$6.89M +50.1% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-16
Q3 2014 -$42.6M -$6.9M +$4.41M +39% Jul 1, 2014 Sep 30, 2014 10-K 2015-03-16
Q2 2014 -$47M -$10.2M +$77.8K +0.76% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$47.1M -$11.7M -$4.4M -59.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$42.7M -$13.8M -$6.55M -90.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$36.2M -$11.3M -$2.18M -23.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$34M -$10.3M -$4.44M -75.8% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$29.5M -$7.34M -$327K -4.66% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$29.2M -$7.2M +$405K +5.32% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$29.6M -$9.12M -$29M -146% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$650K -$5.86M -$3.67M -168% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $3.02M -$7.01M -$2.59M -58.6% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $5.61M -$7.61M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 $19.8M +$22.2M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$2.19M +$40.9M +94.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$4.42M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$2.38M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$43.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.